As per the research report, the size of the Europe Catheter Stabilization Devices Market is valued at USD 293.22 million in 2023 and estimated to be growing at a CAGR of 7.32%, to reach USD 417.44 million by 2028 during the forecast period 2023 to 2028.
The catheter stabilization devices market in Europe is being driven by a growing senior population, rising prevalence of lifestyle conditions, rising healthcare costs, and an increasing desire for less invasive surgeries.
One of these variables is the number of procedures performed in trauma centers and hospitals that require a catheter during the procedure. As a result, catheter stability and security are more important than ever. The market is expected to develop over the forecast period due to the rising demand for minimally invasive procedures across Europe. Catheter stabilizing devices will become increasingly important as the need for less invasive treatments grows. Unfortunately, hospitals and clinics cannot quickly adapt to these devices because of catheter product recalls.
Government support programs to strengthen the healthcare system and promote economic growth in developing countries will move the regional market forward. Hospitalizations for cardiovascular patients are also on the rise, especially in late adulthood and old age, when patients have a variety of symptoms.
Companies like Bard, Baxter, and others manufacture arterial securement devices widely used in hospitals and clinics. These companies have well-developed distribution systems. The demand for arterial securement devices has increased due to these variables, resulting in improved surgical outcomes. As a result, clinical stabilization devices are predicted to dominate the market during the forecast period.
Alternative devices and the high cost of technologically advanced items limit the expansion of the European catheter stabilization devices industry.
The most severe risk of using a urinary catheter is that bacteria may enter your body. Infections of the urethra, bladder, and, less commonly, kidneys can result from this. Urinary tract infections are the name for this infection (UTIs).
Pneumothorax, arterial puncture, haem thorax, stroke, arrhythmias, and nerve injury are all substantial risks associated with installing these lines. One of the most common early problems following a central line insertion is cardiac issues. Because the guidewire comes into contact with the right atrium, physicians will experience arrhythmias during or shortly after the insertion.
This research report on the Europe Catheter Stabilization Devices Market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, the Europe Catheter Stabilization Devices Market is projected to drive the market due to the frequency of cardiovascular disorders and cancer incidences. In addition, chronic lifestyle diseases and unintentional incidents are on the rise at an alarmingly high rate.
The U.K Catheter Stabilization Devices Market is predicted to grow at significant growth and is well known for hospital management and infrastructure in terms of surgical methods. In addition, healthcare organizations can afford the high costs of therapy and devices, which is propelling the industry forward.
The France Catheter Stabilization Devices Market is predicted to increase rapidly. The European Medical Agency (EMA) for catheter stabilization devices market and the increased central line-associated bloodstream infection (CLABSI) cases. The stipulation of healthcare costs accelerates the market's expansion. According to the OECD, Germany spent EUR 321 billion on healthcare in 2014.
The Germany Catheter Stabilization Devices Market has experienced significant growth during the assessment period. The market expansion was aided by increasing government assistance and extensive funding to introduce innovative items. THE SEATS ARE LOCKED The Foley stabilization device is a strapless device that locks and stabilizes the Foley catheter.
KEY MARKET PLAYERS
Key players operating in the Europe Catheter Stabilization Devices Market profiled in this report are Medtronic plc (U.S.), C. R. Bard, Inc. (U.S.), Centurion Medical Products (U.S.), Smiths Group plc (U.K.), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), 3M Company (U.S.), and M.C. Johnson Company, Inc. (U.S.).,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com